REFR RESEARCH FRONTIERS INC
Patent Owners & Lessors · Nasdaq · SEC CIK 793524 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $77,041 | $86,346 | $136,319 | $72,123 | $359,444 | $129,904 | $559,776 | $178,151 |
| R&D expense | $119,574 | $128,884 | $145,350 | $135,023 | $141,746 | $169,086 | $162,877 | $160,190 |
| Operating income | -$518,121 | -$669,754 | -$530,413 | -$773,543 | -$303,944 | -$815,104 | -$239,577 | -$624,284 |
| Net income | -$510,304 | -$660,168 | -$525,365 | -$765,563 | -$298,508 | -$803,826 | -$177,687 | -$607,940 |
| EBITDA | -$517,805 | -$669,267 | -$530,269 | -$771,344 | -$301,065 | -$812,240 | -$236,717 | -$620,517 |
| EPS (basic) | -0.01 | -0.02 | -0.02 | — | -0.01 | -0.02 | -0.01 | — |
| EPS (diluted) | -0.01 | -0.02 | -0.02 | — | -0.01 | -0.02 | -0.01 | — |
| Weighted avg. shares (diluted) | 34.87M | 34.87M | 34.16M | — | 33.65M | 33.65M | 33.65M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $644,628 | $1.09M | $1.28M | $664,299 | $1.13M | $1.27M | $1.35M | $1.99M |
| Receivables | $223,853 | $207,955 | $544,985 | $408,666 | $371,878 | $536,373 | $969,059 | $658,213 |
| Current assets | $982,668 | $1.46M | $2.02M | $1.14M | $1.61M | $1.97M | $2.52M | $2.75M |
| PP&E, net | $2,559 | $2,867 | $3,147 | $3,393 | $6,355 | $9,095 | $12,082 | $15,052 |
| Total assets | $1.96M | $2.48M | $3.08M | $2.25M | $2.77M | $3.17M | $3.77M | $4.04M |
| Current liabilities | $444,603 | $410,885 | $316,107 | $297,877 | $212,088 | $280,235 | $210,708 | $269,027 |
| Total liabilities | $1.35M | $1.35M | $1.30M | $1.32M | $1.27M | $1.37M | $1.34M | $1.44M |
| Shareholders' equity | $612,789 | $1.12M | $1.78M | $933,626 | $1.50M | $1.80M | $2.43M | $2.60M |
| Shares outstanding | 34.87M | 34.87M | 34.87M | 33.65M | 33.65M | 33.65M | 33.65M | 33.65M |
| Cash flow statement | ||||||||
| Operating cash flow | -$443,320 | -$191,307 | -$759,931 | -$465,947 | -$143,513 | -$78,430 | -$641,271 | $47,080 |
| Capital expenditure | $8 | $38 | $67 | $144 | $373 | $99 | $110 | $881 |
| Free cash flow | -$443,328 | -$191,345 | -$759,998 | -$466,091 | -$143,886 | -$78,529 | -$641,381 | $46,199 |
| Investing cash flow | -$8 | -$38 | -$67 | -$144 | -$373 | -$99 | -$110 | -$881 |
| Financing cash flow | $0 | $0 | $1.38M | — | — | — | — | $300,000 |
| Depreciation & amortization | $316 | $487 | $144 | $2,199 | $2,879 | $2,864 | $2,860 | $3,767 |
| Stock-based compensation | — | — | — | $199,671 | $0 | — | — | — |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.